Methionine/Inositol/Choline (Partell) – sterility concern (2018)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Methionine15mg/Inositol 50mg/Choline 100mg, packaged in a) 5mL and b) 50 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800
Brand
Partell Specialty Pharmacy
Lot Codes / Batch Numbers
a) Lot #: 20180129@18, BUD 4/14/2018 b) Lot #: 20171127@6, 20180207@12, 20180108@16, BUD 04/14/2018.
Products Sold
a) Lot #: 20180129@18, BUD 4/14/2018 b) Lot #: 20171127@6, 20180207@12, 20180108@16, BUD 04/14/2018.
Partell Specialty Pharmacy is recalling Methionine15mg/Inositol 50mg/Choline 100mg, packaged in a) 5mL and b) 50 mL amber vial, Rx only, Par due to Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
NV
Page updated: Jan 7, 2026